- News Releases
For news outlets covering the solanezumab Alzheimer’s drug trial results: Mayo Clinic Alzheimer’s expert and neurologist Ronald Petersen, M.D. sees good news and bad news in the trial results announced today, regarding the Eli Lilly Alzheimer’s drug, solanezumab. MP3 audio clips and a photo of Dr. Petersen are available in the downloads above; transcripts of the sound bites are below. Dr. Petersen is a neurologist with Mayo Clinic in Rochester, Minn., chair of the federal Advisory Council on Alzheimer's Research, Care and Services and a leader in drafting the first U.S. national plan to address Alzheimer’s disease. To interview Dr. Petersen, please contact: Brian Kilen 507-284-5005 (days) 507-284-2511 (evenings) email@example.com.
The physical benefits of the Olympic sports are pretty obvious: strength, endurance and agility, to name a few. But did you know they also can ...